Viemed Healthcare, Inc. provided earnings guidance for the first quarter of 2024. For the quarter, the company expects to generate net revenues of approximately $49.7 million to $51.0 million during the first quarter of 2024 and assumes that the 75/25 blended Medicare reimbursement rate adjustment in non-rural, non-competitive bid areas is not extended.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.31 USD | +3.75% | +5.46% | +5.86% |
Apr. 02 | Viemed Healthcare, Inc. acquired an unknown majority interest in East Alabama Homemed, LLC. | CI |
Mar. 18 | Viemed Healthcare, Inc.(NasdaqCM:VMD) added to S&P TMI Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.86% | 323M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- VMD Stock
- News Viemed Healthcare, Inc.
- Viemed Healthcare, Inc. Provides Earnings Guidance for the First Quarter of 2024